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Cocoa powder has twice more antioxidants than red wine and three times more than
green tea. Ten percent of its weight is made up of ﬂavonoids. Cocoa has antioxidant
and anti-inﬂammatory effects by downregulating cyclooxigenase-2 receptors expression in
the endothelium and enhancing nitric oxide bioavailability. There are evidences that while
polyphenols ingestion have cardioprotective effects in the adult, it may have deleterious
effect on the fetus if ingested by the mother on the third trimester of pregnancy, causing
intrauterine fetal ductus arteriosus (DA) constriction. Polyphenols present in many foods
and their anti-inﬂammatory and antinociceptive activities have been shown to be as or
more powerful than those of indomethacin. These effects are dependent on the inhibition
of modulation of the arachidonic acid and the synthesis of prostaglandins, especially E-2,
which is responsible for fetal DA patency. So, we hypothesized that this same mechanism
is responsible for the harmful effect of polyphenol-rich foods, such as cocoa, upon the fetal
DA after maternal intake of such substances in the third trimester of pregnancy, thereby
rising the perspective of a note of caution for pregnant women diet.
Keywords: Cocoa, polyphenols, anti-inflammatory, antioxidant, fetal ductus arteriosus, ductal constriction,
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Cocoa powder has twice more antioxidants than red wine and
three times more than green tea. Ten percent oh its weight is made
up of ﬂavonoids. Its sub-product, dark chocolate, shows in its
composition 53.5 mg of catechins in 100 g of chocolate, whereas
milk chocolate has 15.9 mg/100 g (Arts et al., 1999).
Biologic activity of polyphenols is related to interference in the
inﬂammatory cascade, with inhibition of prostaglandin synthesis
and mediation of nitric oxide synthase 5. Among the discussed
effects of cocoa consumption are interferences with vascular func-
tion, platelet reactivity and inﬂammatory processes, suggesting
cardioprotective properties of some constituents (Arranz et al.,
2013). However, the inﬂammatory background in disease devel-
opment, like the starting point of pro-inﬂammatory cytokine
release and metabolite production, is a central target for pre-
ventive actions. In line with this, we aim to discuss potential
interferences of cocoa antioxidantswith central anti-inﬂammatory
mechanisms, by focusing on pathways involved in cyclooxygenase
and nitric oxide responses, and its potential side effects.
Cocoa polyphenols modulate nuclear factor kappaB (NF-κB)
activity, a protein complex involved in the transduction cascades
that play a key role in inﬂammatory response and carcinogenesis
(Sies et al., 2005; Romier-Crouzet et al., 2009). Cocoa polyphenols
are potent inhibitors of the kinase activity of mitogen-activated
kinase kinase (MEK), and this inhibition subsequently suppresses
COX-2 expression in TPA induced inﬂammation (Heptinstall
et al., 2006; Kang et al., 2008). Although, this effect was not
observed with cocoa theobromine. MEK is a dual speciﬁcity pro-
tein kinase that phosphorylates the downstream target ERK on
speciﬁc tyrosine and threonine residues. Because the expression of
COX-2 is primarily regulated by eukaryotic transcription factors
such as NF-κB and activator protein (AP)-1, inhibition of AP-1
and/or NF-κB might lead to the suppression of cell transforma-
tion through the blocking of COX-2 expression (Hsu et al., 2000;
Lee and Lee, 2006; Kang et al., 2008). Stimulation of cells with
various tumor promoters an pro-inﬂammatory substances results
in the activation of AP-1 and/or NF-κB by a series of upstream
kinases, including those belonging to the mitogen-activated pro-
tein (MAP) kinase family. The MAP kinases include extracellular
signal-regulated protein kinase (ERK), c-Jun N-terminal kinase
(JNK), and p38 MAP kinase.
Cocoas (–)-epicatechin and (+)-catechin reduce NF-κB capac-
ity of binding to DNA by preventing the phosphorylation of
inhibitor κB (IκB) (Selmi et al., 2006). In a complementary study,
Zhang et al. (2006) investigated the effects of procyanidins on
COX2 expression on THP-1 cells. NF-κB suppression was accom-
panied by ERK, JNK, and MAPK inhibition and consequently
COX2 expression decreased. These effects occurred by the sta-
bilization of IκB protein to its active site in the NFκB complex
(Zhang et al., 2006; Kang et al., 2008).
Furthermore, procyanidin B2, a polyphenol with potent anti-
inﬂammatory effect, inhibited inﬂammasome activation by the
inactivation of the NF-κB signaling pathway, the ﬁrst stage
required for the transcription of inﬂammasome precursors,
through the inhibition of p65 nuclear expression and DNA
binding, resulting in the transcriptional repression of target
genes, such as COX2, iNOS and production of IL-6 and NO
(Martinez-Micaelo et al., 2014).
Ingestion of cocoa polyphenlos interferes in NO metabolism
in various spheres. Procyanidins favor NO synthesis and, thereby,
inhibit the formation of superoxide and peroxynitrite (Wollgast
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and Anklam, 2000). These phenolic compounds cause arterial
vasodilation (Corti et al., 2009), decrease infact size (Yamazaki
et al., 2014) and increased walking distance in patients with
peripheral artery disease by NO mediated mechanisms (Loffredo
et al., 2014). Cocoa diminishes arginase activity in endotelial
cells, increases L-arginine levels (a substrate for NO produc-
tion by eNOS) and increases NO metabolites excretion in urine
(Andújar et al., 2012). Ramirez-Sanchez et al. (2010) andMoreno-
Ulloa et al. (2014), have described that epicatechin acts over
eNOS by serine 633 and 1177 phosphorylation and threonine
495 dephosphorylation, which in turn, exerts effect on the
intracellular pathway of PI3K, enhancing NO formation. Fur-
thermore, epicatechin causes eNOS uncoupling from caveolin1
(cav-1), by intracellular Ca2+ increase, at least, partially medi-
ated by Ca2+/CaMKII pathways (Ramirez-Sanchez et al., 2010).
NO is an essential mediator of endothelial function, unless
it is excessively produced under oxidative stress conditions, it
exerts a predominantly antioxidant and anti-inﬂammatory func-
tion. Although, under pathological conditions, the increased
NOS activity may not translate into increased NO produc-
tion. Reduced NO bioavailability through eNOS “uncoupling”
from cav-1 is a contributing factor to reduced local NO in
various endothelial dysfunctional injuries, like pulmonary hyper-
tension (Zuckerbraun et al., 2011). All isoforms of NOS utilize
L-arginine as the substrate, and molecular oxygen and reduced
nicotinamide-adenine-dinucleotide phosphate (NADPH) as co-
substrates. Flavin adenine dinucleotide (FAD), Flavin mononu-
cleotide (FMN), and (6R-)5,6,7,8-tetrahydro-L-biopterin (BH4)
are cofactors of all isozymes (Katusic, 2001). Uncoupling occurs
under conditions of reduced BH4 availability where eNOS pro-
duces ROS rather than NO. Due to the enhanced oxidative stress
seen in many pathological process, an increased degradation of
NO by its reaction with O2–· will occur. However, oxidative stress
has also been shown to convert eNOS from an NO-producing
enzyme to an enzyme that generates O2–·. Superoxide anions have
been recognized as contributing to vascular dysfunction, through
mechanisms including endothelial dysfunction, vascular smooth
muscle cell growth, lipid peroxidation, and inﬂammation (Schewe,
2000; Förstermann and Sessa, 2012).
The effects of ﬂavanols, on the thrid trimester of pregnancy,
have not yet been fully described. The human placental function
depends onNOandPGI biosynthesis. On the third trimester, there
is a relative placentary deﬁciency of BH4 (Kukor et al., 2000). As
pregnancy progresses, oxidative stress in the placenta prepares the
uterus for labor (Cindrova-Davies et al., 2007). In this period, NO
production may lead to greater risk of nitrative damage.
Polyphenol-rich foods consumption have a positive effect in
general health, although deleterious effect on the fetus have been
reported if ingested by the mother on the third trimester of preg-
nancy (Luchese et al., 2003; Zielinsky et al., 2010a,b, 2012a,b, 2013;
Zielinsky and Busato, 2013; Bubols et al., 2014). The negative
effects on the fetus are possibly due to its anti-inﬂammatory effect
on the ductus arteriosus (DA). Fetal circulation has character-
istic features, being morphologically and functionally different
from extrauterine circulation. The DA plays a fundamental role
in directing the blood ﬂow to fetal inferior body parts. Basically,
the DA directs 80–85% of the right ventricular output arising
from the superior vena cava, coronary sinus, and a small part
from the inferior vena cava to descending aorta. Its histological
structure is made up predominantly by a thick muscular layer, dif-
ferently from the aorta and the pulmonary artery, which increases
with gestational age. The ﬁbers have a circumferential orienta-
tion, especially at the external layers, facilitating and making
effective ductal constriction. These factors may generate lumen
alterationswhichmay cause fetal andneonatal complications, such
as heart failure, hydrops, neonatal pulmonary hypertension, and
even death. Classically, maternal administration of indomethacin
and/or other anti-inﬂammatory drugs interfere in prostaglandins
metabolism, causing ductal constriction. In recent years, a growing
body of evidence has shown that cocoa, as previously discussed,
but also herbs, fruits, nuts, and a wide diversity of substances
commonly used in daily diets have deﬁnitive effects upon the
metabolic pathway of inﬂammation, with consequent inhibition
of prostaglandins synthesis (Zielinsky et al., 2010a). This anti-
inﬂammatory action, when polyphenol-rich substances such as
cocoa are ingested during the third trimester of pregnancy, may
inﬂuence the dynamics of fetal DA ﬂow.
Intrauterine constriction of the fetal DA can be a devastat-
ing event that may lead to pulmonary hypertension, heart failure
or even perinatal death. Maternal ingestion of anti-inﬂammatory
COX inhibitors are the leading cause of DA constriction, although,
up to 65% of cases are considered as of unknown origin (Luchese
et al., 2003). We have already shown that after administration of
green tea or grape juice to pregnant ewe in the near term the
fetuses showed echocardiographic or morphologic characteristics
of ductal constriction (Zielinsky et al., 2010a). In another experi-
mental study, the ingestion of green tea as the only source of liquid
caused an increase in the ﬂow velocities of the DA, right ventricle
hypertrophy and pulmonary hypertension in the echocardiogram
of fetal lamb. The histological analysis showed an increase in the
avascular media layer, conﬁrming ductal constriction (Zielinsky
et al., 2012a). Observational studies in humans also showed that
polyphenol rich food ingestion on the third trimester of preg-
nancy caused ductal contriction (Zielinsky et al., 2010a,b, 2012b;
Zielinsky andBusato, 2013) and that the restriction of polyphenols
from maternal diet reverted the constrictive effect unto normal
ﬂow through the DA even in normal pregnancies (Zielinsky et al.,
2012b, 2013). Furthermore, 2 weeks of daily supplementation of
polyphenol rich food (total polyphenol of >3100mg/day) to preg-
nant ewe caused ductal constriction and decreased plasmatic lipid
peroxidation (TBARS) and increased catalase and glutathione per-
oxidase levels in maternal plasma when compared to normal diet
group (Bubols et al., 2014). Even though there was a signiﬁcant
increase of protein carbonylation and lower nitrite/nitrate ratio,
PGE2 level were unaltered in maternal blood samples (Bubols
et al., 2014; Table 1). Speciﬁcally in relation to maternal cocoa
exposition, in an experimental rodent model of ductal constric-
tion, the administration of one dose of 720mg/kg of cocoa powder
solution through gastric gavage on the last third of pregnancy
caused fetal ductal constriction similar to indomethacin 10 mg/kg,
but did not alter oxidative stress markers or antioxidant enzymes
in the mother or the fetus (submitted).
In short, the ongoing line of investigation relating maternal
exposure to polyphenol-rich substances, including cocoa, in late
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Table 1 | Effect of Cocoa, chocolate and polyphenol rich substances and their beneficial effect on the adult or harmful effect on the fetus.
Reference Substance Population Outcome Overall Effect
Hermann et al. (2006) Dark chocolate and
Liquid cocoa
Healthy humans Improved endothelial function. Decreased BP Beneﬁcial
Innes et al. (2003) Dark chocolate Healthy humans Inhibited collagen-induced platelet aggregation Beneﬁcial
Flammer et al. (2012) Dark chocolate Humans with heart failure Increased FMD Beneﬁcial
Loffredo et al. (2014) Dark chocolate Humans with peripheral
arterial disease
Increased FMD, MWD and MWT Beneﬁcial
Parsaeyan et al. (2014) Cocoa powder Humans with Diabetes Lowered blood cholesterol, triglyceride,
LDL-cholesterol, andTNF-α, hs-CRP, IL-6, by
Bioinformatics and virtual analysis inhibited COX-2
Beneﬁcial
Morrison et al. (2014) Epicatechin Mice with atherosclerosis Lowers NFkB and atherosclerotic plaque Beneﬁcial
Lee et al. (2006) Cocoa polyphenols Mice and in vitro Inhibited COX2 expression and superoxide formation Beneﬁcial
Zielinsky et al. (2010b) Polyphenols rich diet Healthy pregnant humans Caused fetal CDA Harmful
Zielinsky et al. (2013) Polyphenols rich diet Healthy pregnant humans Polyphenol restriction from diet caused fetal ductal
dilation
Harmful
Zielinsky et al. (2012b) Polyphenols rich diet Pregnant humans with fetal
CDA
Polyphenol restriction from diet caused fetal ductal
dilation
Harmful
Zielinsky et al. (2007) Green tea, mate tea,
grape juice
Pregnant ewe Fetal ductus arteriosus constriction Harmful
Zielinsky et al. (2012a) Green tea Pregnant ewe Fetal ductus arteriosus constriction Harmful
Bubols et al. (2014) Polyphenols rich diet Pregnant ewe Fetal ductus arteriosus constriction, lowers oxidative
stress markers
Harmful
BP, blood pressure; DAC, ductus arteriosus constriction; FMD, ﬂow mediated dilatation; COX, cyclooxygenase; MWD, mean walking distance; MWT, mean walking
time; CDA, constriction of ductus arteriosus.
pregnancy, points toward the perspective of deleterious effects
to the fetus, mainly fetal DA constriction, which carries a high
risk of neonatal pulmonary hypertension and its potential severe
consequences. Additional studies are necessary to establish dose
ranges and serum concentrations necessary to determine safety
and well being in the human setting.
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